FDA gives nod to new flu vaccine from GlaxoSmithKline

08/18/2013 | Family Practice News · PMLive.com (U.K.)

The FDA has approved GlaxoSmithKline's Flulaval Quadrivalent vaccine for two A and two B strains of seasonal influenza. "Trivalent vaccines do reduce influenza risk, even in years when a vaccine strain-mismatch occurs, though quadrivalent influenza vaccines are the important next step in broadening strain coverage," said GSK's Dr. Leonard Friedland. The vaccine will be distributed for the coming flu season, and it is GSK's second quadrivalent flu vaccine to be approved in the U.S.

View Full Article in:

Family Practice News · PMLive.com (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA